These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6754512)

  • 1. Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women.
    Kicovic PM; Cortés-Prieto J; Luisi M; Milojevic S; Franchi F
    Reproduccion; 1982; 6(2):81-91. PubMed ID: 6754512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of a new steroid (Org OD 14) in the climacteric syndrome].
    Cittadini J; Ben J; Badano AR; Denari HJ; Quiroga S; Marcus AE; Schlaen I; Figueroa Casas PR
    Reproduccion; 1982; 6(2):69-79. PubMed ID: 6814971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients.
    Nevinny-Stickel J
    Arch Gynecol; 1983; 234(1):27-31. PubMed ID: 6660926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New steroid for the climacteric syndrome.
    Kicovic PM
    Minerva Endocrinol; 1989; 14(1):63-7. PubMed ID: 2659954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term placebo-controlled efficacy and safety study of Org OD 14 in climacteric women.
    Benedek-Jaszmann LJ
    Maturitas; 1987; Suppl 1():25-33. PubMed ID: 3306289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of tibolone and estrogen replacement therapy on echocardiographic basic cardiac functions in post-menopausal women: a randomized placebo controlled study.
    Taskin O; Muderrisoglu H; Akar M; Simsek M; Mendilcioglu I; Kursun S
    Maturitas; 2004 Aug; 48(4):354-9. PubMed ID: 15283927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Org OD 14 for the treatment of climacteric complaints.
    De Aloysio D; Fabiani AG; Mauloni M; Bottiglioni F
    Maturitas; 1987; Suppl 1():49-65. PubMed ID: 3306291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Org OD 14 in the treatment of climacteric complaints.
    Trévoux R; Dieulangard P; Blum A
    Maturitas; 1983 Aug; 5(2):89-96. PubMed ID: 6633272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
    Winther K; Rein E; Hedman C
    Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo.
    Crona N; Samsioe G; Lindberg UB; Silfverstolpe G
    Maturitas; 1988 Mar; 9(4):303-8. PubMed ID: 3288845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women.
    Komesaroff PA; Black CV; Cable V; Sudhir K
    Climacteric; 2001 Jun; 4(2):144-50. PubMed ID: 11428178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A preliminary report on the treatment of climacteric symptoms with Org OD14].
    Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):539-41, 569-70. PubMed ID: 8313747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the synthetic steroid Org OD14 on fibrinolysis and blood lipids in postmenopausal women.
    Walker ID; Davidson JF; Richards A; Yates R; McEwan HP
    Thromb Haemost; 1985 Jun; 53(3):303-5. PubMed ID: 3901389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14.
    Cortes-Prieto J
    Maturitas; 1987; Suppl 1():67-72. PubMed ID: 3306292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of Org OD 14.
    Tax L; Goorissen EM; Kicovic PM
    Maturitas; 1987; Suppl 1():3-13. PubMed ID: 3306290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical use of a preparation based on phyto-oestrogens in the treatment of menopausal disorders.
    Russo R; Corosu R
    Acta Biomed; 2003 Dec; 74(3):137-43. PubMed ID: 15055018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
    Landgren MB; Helmond FA; Engelen S
    Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L; Gass M; Constantine G; Olivier S;
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent].
    De Leo V; Lanzetta D; Cazzavacca R; Morgante G
    Minerva Ginecol; 1998 May; 50(5):207-11. PubMed ID: 9677811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.